New heart valve device enters human testing
Disease control
Recruiting now
This early-stage study is testing a new device called the ReValve System to replace leaky mitral valves in the heart. The trial will enroll 20 adults with severe mitral regurgitation who are experiencing symptoms like shortness of breath and fatigue. Researchers will assess wheth…
Phase: PHASE1 • Sponsor: ReValve Solutions Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC